- Home
- ELVN vs THRM Comparison
ELVN vs THRM Comparison
Compare ELVN & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | THRM |
|---|---|---|
| Founded | 2016 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2020 | 1993 |
Fundamental Metrics
Financial Performance| Metric | ELVN | THRM |
|---|---|---|
| Price | $27.69 | $31.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $41.00 | $39.00 |
| AVG Volume (30 Days) | ★ 1.6M | 196.0K |
| Earning Date | 03-12-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.99 |
| Revenue | N/A | ★ $1,468,728,000.00 |
| Revenue This Year | N/A | $3.56 |
| Revenue Next Year | N/A | $2.32 |
| P/E Ratio | ★ N/A | $32.22 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.30 | $22.75 |
| 52 Week High | $29.98 | $40.41 |
Technical Indicators
Market Signals| Indicator | ELVN | THRM |
|---|---|---|
| Relative Strength Index (RSI) | 69.11 | 27.10 |
| Support Level | $24.90 | $36.25 |
| Resistance Level | $28.69 | $37.02 |
| Average True Range (ATR) | 1.58 | 1.34 |
| MACD | 0.04 | -0.63 |
| Stochastic Oscillator | 80.11 | 5.32 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About THRM Gentherm Inc
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.